ZANGANEH MAHKAM purchased 110.32K shares of SUMMIT THERAPEUTICS INC. on the open market
Open‑market purchase worth $411.1K. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 3/27/2024ACC: 0001599298-24-000047
+110.32K
Net shares
Net buyer
$411.1K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
110.32K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+30K
Price / share
$3.75
Trade value
$112.50K
% of position
New position
3/26/2024
0.00→30K
Common Stock
Direct
Shares
+26K
Price / share
$3.72
Trade value
$96.72K
% of position
5.3%
3/27/2024
494.81K→520.81K
Common Stock
Indirect
Shares
+34.32K
Price / share
$3.72
Trade value
$127.67K
% of position
0.1%
3/27/2024
24.89M→24.92M
Common Stock
Indirect
Shares
+20K
Price / share
$3.71
Trade value
$74.20K
% of position
66.7%
3/27/2024
30K→50K
Total
Net shares
+110.32K
Net value
$411.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/26/2024 | P · Purchase | +30K | $3.75 | $112.50K | New position | 0.00 | 30K |
| Common Stock Direct | 3/27/2024 | P · Purchase | +26K | $3.72 | $96.72K | 5.3% | 494.81K | 520.81K |
| Common Stock Indirect | 3/27/2024 | P · Purchase | +34.32K | $3.72 | $127.67K | 0.1% | 24.89M | 24.92M |
| Common Stock Indirect | 3/27/2024 | P · Purchase | +20K | $3.71 | $74.20K | 66.7% | 30K | 50K |
| Total | +110.32K | $411.09K | ||||||
Derivative Transactions0
No derivative transactions reported